Study Stopped
Low enrollment.
A Multicenter Data Registry for Outcomes From Surgical Treatment of Atrial Arrhythmias
STAR
Surgical Treatment for Atrial Arrhythmia Registry (STAR Outcomes)
1 other identifier
observational
106
1 country
1
Brief Summary
Minimally invasive surgical treatment of atrial fibrillation is safe and effective at controlling atrial fibrillation. The fundamental goal of STAR Outcomes registry is to improve the understanding of the efficacy of surgical ablation intervention in the treatment of atrial fibrillation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 4, 2008
CompletedFirst Posted
Study publicly available on registry
September 5, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedMay 27, 2013
May 1, 2013
4 years
September 4, 2008
May 24, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Minimally invasive surgical treatment of atrial fibrillation is safe and effective at controlling atrial fibrillation
One Year
Interventions
Minimally Invasive Surgical Correction of Atrial Fibrillation.
Eligibility Criteria
Adult patients with paroxysmal (intermittent) or persistent atrial fibrillation undergoing surgical correction.
You may qualify if:
- Adult patients with paroxysmal (intermittent) or persistent atrial fibrillation
- \> 18 years of age
You may not qualify if:
- Patients unable to give adequate informed consent
- Patients who are known to be pregnant, plan to become pregnant or are lactating
- Inability to return for follow up
- Patients who are prison inmates or institutionalized
- Patients in an emergency state
- Patients under the age of 18
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
Related Publications (3)
Saini A, Hu YL, Kasirajan V, Han FT, Khan MZ, Wolfe L, Gunda S, Koneru JN, Ellenbogen KA. Long-term outcomes of minimally invasive surgical ablation for atrial fibrillation: A single-center experience. Heart Rhythm. 2017 Sep;14(9):1281-1288. doi: 10.1016/j.hrthm.2017.04.029. Epub 2017 Apr 22.
PMID: 28438723DERIVEDKasirajan V, Spradlin EA, Mormando TE, Medina AE, Ovadia P, Schwartzman DS, Gaines TE, Mumtaz MA, Downing SW, Ellenbogen KA. Minimally invasive surgery using bipolar radiofrequency energy is effective treatment for refractory atrial fibrillation. Ann Thorac Surg. 2012 May;93(5):1456-61. doi: 10.1016/j.athoracsur.2012.01.110.
PMID: 22541178DERIVEDKron J, Kasirajan V, Wood MA, Kowalski M, Han FT, Ellenbogen KA. Management of recurrent atrial arrhythmias after minimally invasive surgical pulmonary vein isolation and ganglionic plexi ablation for atrial fibrillation. Heart Rhythm. 2010 Apr;7(4):445-51. doi: 10.1016/j.hrthm.2009.12.008. Epub 2009 Dec 16.
PMID: 20156608DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vigneshwar Kasirajan, MD
Virginia Commonwealth University
- PRINCIPAL INVESTIGATOR
Kenneth Ellenbogen, MD
Virginia Commonwealth University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2008
First Posted
September 5, 2008
Study Start
September 1, 2008
Primary Completion
September 1, 2012
Study Completion
December 1, 2012
Last Updated
May 27, 2013
Record last verified: 2013-05